The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
Open accessAbstract
The Catalogue of Somatic Mutations in Cancer (COSMIC) Cancer Gene Census (CGC) is an expert-curated description of the genes driving human cancer that is used as a standard in cancer genetics across basic research, medical reporting and pharmaceutical development. After a major expansion and complete re-evaluation, the 2018 CGC describes in detail the effect of 719 cancer-driving genes. The recent expansion includes functional and mechanistic descriptions of how each gene contributes to disease generation in terms of the key cancer hallmarks and the impact of mutations on gene and protein function. These functional characteristics depict the extraordinary complexity of cancer biology and suggest multiple cancer-related functions for many genes, which are often highly tissue-dependent or tumour stage-dependent. The 2018 CGC encompasses a second tier, describing an expanding list of genes (currently 145) from more recent cancer studies that show supportive but less detailed indications of a role in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We identified 391 out of the 622 curated COSMIC cancer-related and AML-related genes located inside the altered TADs in at least one sample, and more than 100 are recurrent across multiple samples (Extended Data Fig. 3b)4,24,25.”
From Subtype-specific 3D genome alteration in acute myeloid leukaemia (2022) · cites this paper as [24]
Experimental — accuracy not yet measuredIn the citing paper
“four interact with or signal through KRAS16,38 or are known oncogenes or tumor suppressors39: TP53, RNF43, MAP2K4, and RBM10”
From The origins and genetic interactions of KRAS mutations are allele- and tissue-specific (2021) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Processing of primary microRNAs by the Microprocessor complex
Denli, A. M., Tops, B. B. J., Plasterk, R. H. A., Ketting, R. F., & Hannon, G. J. (2004) · Nature · doi:10.1038/nature03049 · Cited by 2,784
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Cited by
Sorted by citations
Items 401–500 of 998
frDriver: A Functional Region Driver Identification for Protein Sequence
Lu, X., Wang, X., Ding, L., Li, J., Gao, Y., & He, K. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.3020096 · Cited by 20
The genomic trajectory of ovarian high‐grade serous carcinoma can be observed in STIC lesions
Cheng, Z., Ennis, D. P., Lu, B., Mirza, H., Sokota, C., Kaur, B. S., Singh, N., Saux, O. L., Russo, G., Giannone, G., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6322 · Cited by 24
Chao, A., Huang, C., Yu, W., Lin, C., Lin, H., Chao, A., Lin, C., Chou, H., Huang, K.-G., Huang, H.-J., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-13125-5 · Cited by 21
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures
Satpathy, S., Clark, N. M., Chen, Y., Hosseini, N., Chang, Y.-H., Hsiao, Y., Lei, J. T., Petralia, F., Chen, J., Geffen, Y., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.07.011 · Cited by 23
Borchmann, S. (2021) · Microbiome · doi:10.1186/s40168-021-01039-4 · Cited by 21
Barnett, K. R., Mobley, R. J., Diedrich, J. D., Bergeron, B. P., Bhattarai, K. R., Monovich, A. C., Narina, S., Yang, W., Crews, K. R., Manring, C. S., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100442 · Cited by 22
Synthesis and cytotoxic activity evaluation of novel imidazopyridine carbohydrazide derivatives
Firouzi, M., Haghighijoo, Z., Eskandari, M., Mohabbati, M., Miri, R., Jamei, M. H., Poustforoosh, A., Nazari, S., Firuzi, O., Khoshneviszadeh, M., et al. (2024) · BMC Chemistry · doi:10.1186/s13065-023-01073-3 · Cited by 20
Pre-existing subclones determine radioresistance in rectal cancer organoids
Andel, D., Viergever, B. J., Peters, N. A., Raats, D., van Schelven, S. J., Intven, M., Zandvliet, M. M. J. M., Hagendoorn, J., Rinkes, I. H. M. B., & Kranenburg, O. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113735 · Cited by 20
Shi, H., Williams, M. J., Satas, G., Weiner, A. C., McPherson, A., & Shah, S. P. (2024) · Nature Communications · doi:10.1038/s41467-024-46710-0 · Cited by 19
Kerekes, K., Bányai, L., Trexler, M., & Patthy, L. (2019) · Growth Factors · doi:10.1080/08977194.2019.1626380 · Cited by 20
Hlaváč, V., Holý, P., & Souček, P. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030108 · Cited by 20
Raimondi, D., Passemiers, A., Fariselli, P., & Moreau, Y. (2021) · BMC Biology · doi:10.1186/s12915-020-00930-0 · Cited by 22
Estimating the predictive power of silent mutations on cancer classification and prognosis
Gutman, T., Goren, G., Efroni, O., & Tuller, T. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00229-1 · Cited by 21
Shin, W., Su, Z., Yi, S. S., & Kim, H. J. (2022) · iScience · doi:10.1016/j.isci.2022.105521 · Cited by 22
Terheyden-Keighley, D., Hühne, M., Berger, T. G., Hiller, B., Martins, S., Gamerschlag, A., Sabour, D., Meffert, A., Kislat, A., Slotta, C., et al. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae047 · Cited by 19
Tissue-specific iron levels modulate lipid peroxidation and the FLASH radiotherapy effect
Vilaplana‐Lopera, N., Kim, J. Y., Nam, G., Tullis, I. D. C., Paillas, S., Ruan, J.-L., Lee, P. J., Jiang, Y., Park, S., Hou, T., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07988-0 · Cited by 26
Variable efficiency of nonsense-mediated mRNA decay across human tissues, tumors and individuals
Palou-Márquez, G., & Supek, F. (2025) · Genome biology · doi:10.1186/s13059-025-03727-y · Cited by 24
Flores, S. K., Deng, Y., Cheng, Z., Zhang, X., Tao, S., Saliba, A., Chu, I., Burnichon, N., Gimenez‐Roqueplo, A., Wang, E., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa396 · Cited by 19
dos Santos, F. R. C., dos Santos, F. R. C., Guardia, G. D. A., dos Santos, F. F., & Galante, P. A. F. (2020) · Brazilian Journal of Oncology · doi:10.1055/s-0044-1798347 · Cited by 19
Liu, L., Du, X., Fang, J., Zhao, J., Guo, Y. G., Zhao, Y., Zou, C., Yan, X., & Li, W. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s334041 · Cited by 19
Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer
Mai, Z., Yuan, J., Yang, H., Fang, S., Xie, X., Wang, X., Xie, J., Wen, J., & Fu, J. (2022) · JCI Insight · doi:10.1172/jci.insight.155218 · Cited by 18
A Pan-Cancer Assessment of RB1/TP53 Co-Mutations
Cai, L., DeBerardinis, R. J., Xiao, G., Minna, J. D., & Xie, Y. (2022) · Cancers · doi:10.3390/cancers14174199 · Cited by 19
Yang, H., Gan, L., Chen, R., Li, D., Zhang, J., & Wang, Z. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac528 · Cited by 20
Zhou, W., Jie, Q., Pan, T., Shi, J., Jiang, T., Zhang, Y., Ding, N., Xu, J., Ma, Y., & Li, Y. (2023) · Communications Biology · doi:10.1038/s42003-023-04457-2 · Cited by 19
Radtke, S., Enstrom, M., Pande, D., Duke, E. R., Ojeda, E. F. C., Madhu, R., Owen, S., Kanestrom, G., Cui, M., Perez, A. M., et al. (2023) · Blood · doi:10.1182/blood.2022018564 · Cited by 19
Identification of Cancer Driver Genes by Integrating Multiomics Data with Graph Neural Networks
Song, H., Yin, C., Li, Z., Feng, K., Cao, Y., Gu, Y., & Sun, H. (2023) · Metabolites · doi:10.3390/metabo13030339 · Cited by 19
Phertilizer: Growing a clonal tree from ultra-low coverage single-cell DNA sequencing of tumors
Weber, L. L., Zhang, C., Ochoa, I., & El-Kebir, M. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011544 · Cited by 19
Chen, H., Wang, Z., Gong, L., Wang, Q., Chen, W., Wang, J., Ma, X., Ding, R., Li, X., Zou, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46064-7 · Cited by 19
Dinçer, C., Kaya, T., Keskin, Ö., Gürsoy, A., & Tunçbağ, N. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006789 · Cited by 17
Reprogramming enriches for somatic cell clones with small-scale mutations in cancer-associated genes
Kosanke, M., Osetek, K., Haase, A., Wiehlmann, L., Davenport, C., Schwarzer, A., Adams, F. F., Kleppa, M., Schambach, A., Merkert, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.007 · Cited by 19
Schnöller, L. E., Piehlmaier, D., Weber, P., Brix, N., Fleischmann, D. F., Nieto, A. E., Selmansberger, M., Heider, T., Heß, J., Niyazi, M., et al. (2023) · Radiation Oncology · doi:10.1186/s13014-023-02241-4 · Cited by 19
Arroyo, M., Berral-González, A., Bueno-Fortes, S., Alonso‐López, D., & Rivas, J. D. L. (2020) · Biomolecules · doi:10.3390/biom10050667 · Cited by 18
Gaonkar, K. S., Marini, F., Rathi, K. S., Jain, P., Zhu, Y., Chimicles, N. A., Brown, M., Naqvi, A. S., Zhang, B., Storm, P. B., et al. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03922-7 · Cited by 18
High Concordance of Genomic Profiles between Primary and Metastatic Colorectal Cancer
Lee, S. E., Park, H. Y., Hwang, D., & Han, H. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115561 · Cited by 18
Erkizan, H. V., Sukhadia, S., Natarajan, T. G., Mariño, G., Notario, V., Lichy, J. H., & Wadleigh, R. G. (2021) · Scientific Reports · doi:10.1038/s41598-021-94064-0 · Cited by 18
SWAN pathway-network identification of common aneuploidy-based oncogenic drivers
Bowers, R. R., Jones, C. M., Paz, E. A., Barrows, J. K., Armeson, K. E., Long, D. T., & Delaney, J. R. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac200 · Cited by 18
Douglas, S. P. M., Lahtinen, A., Koski, J., Leimi, L., Keränen, M. A. I., Koskenvuo, M., Heckman, C. A., Jahnukainen, K., Pitkänen, E., Wartiovaara‐Kautto, U., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14364-x · Cited by 18
Buhigas, C., Warren, A. Y., Leung, W., Whitaker, H. C., Luxton, H. J., Hawkins, S. F. C., Kay, J. D., Butler, A. P., Xu, Y., Woodcock, D. J., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01644-3 · Cited by 20
Pan‐Cancer Single‐Nucleus Total RNA Sequencing Using snHH‐Seq
Chen, H., Fang, X., Shao, J., Zhang, Q., Xu, L., Chen, J., Mei, Y., Jiang, M., Wang, Y., Li, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202304755 · Cited by 17
Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia
van der Ham, C. G., Suurenbroek, L. C., Kleisman, M. M., Antić, Ž., Lelieveld, S. H., Yeong, M., Westera, L., Sonneveld, E., Hoogerbrugge, P. M., van der Velden, V. H. J., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02403-7 · Cited by 18
A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer
Rendo, V., Schubert, M., Khuu, N., Rodríguez, M. F. S. P., Whyte, D., Ling, X., van den Brink, A., Huang, K., Swift, M. L., He, Y. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56301-2 · Cited by 20
Ewing, A., Meynert, A. M., Silk, R., Aitken, S., Bendixsen, D. P., Churchman, M., Brown, S. L., Hamdan, A., Mattocks, J., Grimes, G. R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60655-y · Cited by 18
Redesigning HVEM Interface for Selective Binding to LIGHT, BTLA, and CD160
Shrestha, R., Garrett-Thomson, S. C., Liu, W., Almo, S. C., & Fiser, A. (2020) · Structure · doi:10.1016/j.str.2020.07.013 · Cited by 20
Dynamic Interactions of Transcription Factors and Enhancer Reprogramming in Cancer Progression
Zboril, E. K., Yoo, H., Chen, L., & Liu, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.753051 · Cited by 19
The transcriptomic architecture of common cancers reflects synthetic lethal interactions
Haider, S. A., Brough, R., Madera, S., Iacovacci, J., Gulati, A., Wicks, A. J., Alexander, J. J., Pettitt, S. J., Tutt, A. N. J., & Lord, C. J. (2025) · Nature Genetics · doi:10.1038/s41588-025-02108-2 · Cited by 17
Panels and models for accurate prediction of tumor mutation burden in tumor samples
Martínez‐Pérez, E., Molina‐Vila, M. Á., & Marino‐Buslje, C. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00169-0 · Cited by 17
CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness
Lewis, R. I., Maurer, H. C., Singh, N., González-Menéndez, I., Wirth, M., Schick, M., Zhang, L., Isaakidis, K., Scherger, A. K., Schulze, V., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01376-1 · Cited by 17
Identification of cancer-related mutations in human pluripotent stem cells using RNA-seq analysis
Lezmi, E., & Benvenisty, N. (2021) · Nature Protocols · doi:10.1038/s41596-021-00591-5 · Cited by 17
Raghavendran, A., Muthamilselvan, S., & Palaniappan, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0249151 · Cited by 16
The close interaction between hypoxia-related proteins and metastasis in pancarcinomas
López‐Cortés, A., Prathap, L., Ortiz‐Prado, E., Kyriakidis, N. C., Cáceres, Á. L., Armendáriz‐Castillo, I., Vera-Guapi, A., Yumiceba, V., Simbaña‐Rivera, K., Echeverría‐Garcés, G., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15246-y · Cited by 18
Li, S., Chen, J., Chen, J., Wu, B., Liu, J., Guo, Y., Li, M., & Pu, X. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106988 · Cited by 17
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients
Fontana, D., Crespiatico, I., Crippa, V., Malighetti, F., Villa, M., Angaroni, F., Luca, D., Aroldi, A., Antoniotti, M., Caravagna, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41670-3 · Cited by 19
Singh, A. K., Walavalkar, K., Tavernari, D., Ciriello, G., Notani, D., & Sabarinathan, R. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13559 · Cited by 19
Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer
Dobilas, A., Chen, Y., Brueffer, C., Leandersson, P., Saal, L. H., & Borgfeldt, C. (2023) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20423 · Cited by 17
HATCHet2: clone- and haplotype-specific copy number inference from bulk tumor sequencing data
Myers, M. A., Arnold, B. J., Bansal, V., Balaban, M., Mullen, K. M., Zaccaria, S., & Raphael, B. J. (2024) · Genome biology · doi:10.1186/s13059-024-03267-x · Cited by 17
Li, X., Xu, J., Li, J., Gu, J., & Shang, X. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae691 · Cited by 19
Single-cell copy number calling and event history reconstruction
Kuipers, J., Tuncel, A., Ferreira, P., Jahn, K., & Beerenwinkel, N. (2025) · Bioinformatics · doi:10.1093/bioinformatics/btaf072 · Cited by 59
Schmid, V., Lafleur, V. N., Lombardi, O., Li, R., Salama, R. A., Colli, L. M., Choudhry, H., Chanock, S. J., Ratcliffe, P. J., & Mole, D. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-55098-7 · Cited by 17
Ping, Y., Zhou, Y., Hu, J. R., Pang, L., Xu, C., & Xiao, Y. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.06.012 · Cited by 17
Motwani, J., Rodger, E. J., Stockwell, P. A., Baguley, B. C., Macaulay, E. C., & Eccles, M. R. (2021) · Epigenomics · doi:10.2217/epi-2020-0440 · Cited by 18
Gopalan, V., Singh, A., Mehrabadi, F. R., Wang, L., Ruppin, E., Arda, H. E., & Hannenhalli, S. S. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0427 · Cited by 17
Koşaloğlu‐Yalçın, Z., Blazeska, N., Carter, H. K., Nielsen, M., Cohen, E. E. W., Kufe, D. W., Conejo-Garcia, J. R., Robbins, P. F., Schoenberger, S. P., Peters, B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.735609 · Cited by 18
Enhancer methylation dynamics drive core transcriptional regulatory circuitry in pan-cancer
Xu, P., Li, X., Sun, J., Xiong, Z., Hu, H., Ning, S., & Zhi, H. (2022) · Oncogene · doi:10.1038/s41388-022-02359-x · Cited by 17
Harris, K. L., Myers, M. B., McKim, K. L., Elespuru, R. K., & Parsons, B. L. (2019) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22326 · Cited by 17
Huang, A. Y., Zhou, Z., Talukdar, M., Miller, M. B., Chhouk, B., Enyenihi, L., Rosen, I., Stronge, E., Zhao, B., Kim, D., et al. (2024) · doi:10.1101/2024.01.03.574078 · Cited by 16
Möhrmann, L., Rostock, L., Werner, M., Oleś, M., Arnold, J. S., Paramasivam, N., Jöhrens, K., Rupp, L., Schmitz, M., Richter, D., et al. (2025) · Med · doi:10.1016/j.medj.2025.100612 · Cited by 16
Clinical utility of targeted RNA sequencing in cancer molecular diagnostics
Siddaway, R., Glembocki, A. I., Arnoldo, A., Staunton, J., Liu, A. P. Y., Yuki, K. E., Yu, M., Cohen‐Gogo, S., Shlien, A., Villani, A., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03848-8 · Cited by 19
Prediction of Metabolic Profiles from Transcriptomics Data in Human Cancer Cell Lines
Cavicchioli, M. V., Santorsola, M., Balboni, N., Mercatelli, D., & Giorgi, F. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073867 · Cited by 16
Fernández-García, D., Nteliopoulos, G., Hastings, R. K., Rushton, A. J., Page, K., Allsopp, R. C., Ambasager, B., Gleason, K. L. T., Guttery, D. S., Ali, S., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01962-9 · Cited by 17
Kim, E., Han, D., Kim, B. H., Yoo, J., Kim, H. J., Wu, H., Kim, K. S., Kim, H., Han, I., Moon, K. C., et al. (2023) · Modern Pathology · doi:10.1016/j.modpat.2022.100004 · Cited by 16
Pan, F., Iwasaki, M., Wu, W., Jiang, Y.-N., Yang, X., Zhu, L., Zhao, Z., & Cleary, M. L. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022008787 · Cited by 16
Lao, C., Zheng, P., Chen, H., Liu, Q., An, F., & Zhao, L. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05723-8 · Cited by 20
Peng, Y., Yuan, C., Tao, X., Zhao, Y., Yao, X., Zhuge, L., Huang, J., Zheng, Q., Zhang, Y., Hong, H., et al. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-19-401 · Cited by 16
Predictive models for stage and risk classification in head and neck squamous cell carcinoma (HNSCC)
Kumar, S., Patnaik, S., & Dixit, A. (2020) · PeerJ · doi:10.7717/peerj.9656 · Cited by 16
A Global and Integrated Analysis of CINSARC-Associated Genetic Defects
Lesluyes, T., & Chibon, F. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0512 · Cited by 17
Li, Y., Burgman, B., Khatri, I. S., Pentaparthi, S. R., Su, Z., McGrail, D. J., Li, Y., Wu, E., Eckhardt, S. G., Sahni, N., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1015 · Cited by 16
Gene Mutation Classification through Text Evidence Facilitating Cancer Tumour Detection
Gupta, M., Wu, H., Arora, S., Gupta, A., Chaudhary, G., & Hua, Q. (2021) · Journal of Healthcare Engineering · doi:10.1155/2021/8689873 · Cited by 16
RetractedProtein signatures to distinguish aggressive from indolent prostate cancer
Garcia-Marques, F. J., Liu, S., Totten, S. M., Bermudez, A., Tanimoto, C. R., Hsu, E., Nolley, R., Hembree, A., Stoyanova, T. I., Brooks, J. D., et al. (2022) · The Prostate · doi:10.1002/pros.24307 · Cited by 16
Identifying the oncogenic potential of gene fusions exploiting miRNAs
Lovino, M., Montemurro, M., Barrese, V. S., & Ficarra, E. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104057 · Cited by 16
Unterberger, C. J., Maklakova, V. I., Lazar, M., Arneson, P. D., McIlwain, S. J., Tsourkas, P. K., Hu, R., Kopchick, J. J., Swanson, S. M., & Marker, P. C. (2022) · Endocrinology · doi:10.1210/endocr/bqac031 · Cited by 16
Dissecting the heritable risk of breast cancer: From statistical methods to susceptibility genes
Fanfani, V., Zátopková, M., Harris, A. L., Pezzella, F., & Stracquadanio, G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.001 · Cited by 15
Huang, A. Y., Zhou, Z., Talukdar, M., Enyenihi, L., Miller, M. B., Chhouk, B., Rosen, I., Zheng, M., Zhou, M., Yang, A., et al. (2026) · Cell · doi:10.1016/j.cell.2026.03.040 · Cited by 15
Sase, M., Sato, T., Sato, H., Miya, F., Zhang, S., Haeno, H., Kajita, M., Noguchi, T., Mori, Y., & Ohteki, T. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.10.007 · Cited by 17
Biosystem Analysis of the Hypoxia Inducible Domain Family Member 2A: Implications in Cancer Biology
Salazar, C., Yáñez, O., Elorza, Á. A., Cortés, N., García‐Beltrán, O., Tiznado, W., & Ruíz, L. M. (2020) · Genes · doi:10.3390/genes11020206 · Cited by 14
Roberts, A. G. K., Catchpoole, D. R., & Kennedy, P. J. (2022) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqab124 · Cited by 15
Single-cell phylogenies reveal changes in the evolutionary rate within cancer and healthy tissues
Borgsmüller, N., Valecha, M. V., Kuipers, J., Beerenwinkel, N., & Posada, D. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100380 · Cited by 16
Mumphrey, M. B., Hosseini, N., Parolia, A., Geng, J., Zou, W., Raghavan, M., Chinnaiyan, A. M., & Cieslik, M. P. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112965 · Cited by 15
He, F., Bandyopadhyay, A. M., Klesse, L. J., Rogojina, A. T., Chun, S. H., Butler, E. B., Hartshorne, T., Holland, T., Garcia, D. K., Weldon, K. S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43373-1 · Cited by 16
Lykoskoufis, N. M. R., Planet, E., Ongen, H., Trono, D., & Dermitzakis, E. T. (2024) · Nature Communications · doi:10.1038/s41467-023-42405-0 · Cited by 14
Pino, D. C., Badonyi, M., Semple, C. A. M., & Marsh, J. A. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114905 · Cited by 15
Wang, Y., Ju, X., Hua, R., Chen, J., Dai, X., Liu, L., Wang, G., Bai, Y., Hu, H., & Li, X. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02856-8 · Cited by 18
Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan
Yamaguchi, T., Uchida, E., Okada, T., Ozawa, K., Onodera, M., Kume, A., Shimada, T., Takahashi, S., Tani, K., Nasu, Y., et al. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.156 · Cited by 16
mTOR Inhibition Leads to Src-Mediated EGFR Internalisation and Degradation in Glioma Cells
Colella, B., Colardo, M., Iannone, G., Contadini, C., Sáiz-Ladera, C., Fuoco, C., Barilà, D., Velasco, G., Segatto, M., & Bartolomeo, S. D. (2020) · Cancers · doi:10.3390/cancers12082266 · Cited by 16
Zeng, Z., Fu, J., Cibulskis, C., Jhaveri, A., Gumbs, C. E., Das, B., Sánchez‐Espiridión, B., Janssens, S., Taing, L., Wang, J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3251 · Cited by 14
Detection of Rare Germline Variants in the Genomes of Patients with B-Cell Neoplasms
Orgueira, A. M., López, M. C., Raíndo, A. P., Arias, J. Á. D., Rodríguez, B. A., Pérez, L. B., Vence, N. A., López, Á. B., Blanco, A. A., Valentín, P. M., et al. (2021) · Cancers · doi:10.3390/cancers13061340 · Cited by 15
Loveday, C., Garrett, A., Law, P., Hanks, S., Poyastro-Pearson, E., Adlard, J., Barwell, J., Berg, J., Brady, A. F., Brewer, C., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.09.152 · Cited by 13
Gerstner, N., Krontira, A. C., Cruceanu, C., Roeh, S., Pütz, B., Sauer, S., Rex‐Haffner, M., Schmidt, M. V., Binder, E. B., & Arloth, J. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100496 · Cited by 10
A Survey of Compound Heterozygous Variants in Pediatric Cancers and Structural Birth Defects
Miller, D. B., & Piccolo, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.640242 · Cited by 15
Improved supervised prediction of aging-related genes via weighted dynamic network analysis
Li, Q., Newaz, K., & Milenković, T. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04439-3 · Cited by 16
Metadata
- Authors
- Sondka, Z., Bamford, S., Cole, C. G., Ward, S. A., Dunham, I., & Forbes, S. A.
- Affiliations
- Wellcome Sanger Institute (GB)
- European Bioinformatics Institute (GB)
- ORCID
- Dunham, Ian
- Venue
- Nature Reviews Cancer
- Published
- 2018-10-06
- Volume
- 18
- Issue
- 11
- Pages
- 696-705
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC6450507
- OpenAlex
- W2894573839
- Cited by
- 1,597
- References
- 102
- Citations by year
- 2026: 125 · 2025: 227 · 2024: 242 · 2023: 239 · 2022: 260 · 2021: 250 · 2020: 167 · 2019: 75 · 2018: 8
- FWCI
- 13.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- somatic mutations, cancer genetics, gene function, cancer hallmarks, expert curation, cancer genomics
- MeSH terms
- Humans, Mutation, Neoplasms, Censuses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review